Pancreatic Cancer Research

ResearcherFirst Hospital of Jilin UniversityActive in the last 2 years

Xinyu Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8751-5116; OpenAlex author ID A5101782703. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. Co-author DOI 10.1002/advs.202512978↗
  2. CircERC1 facilitates chemoresistance through inhibiting pyroptosis and remodeling extracellular matrix in pancreatic cancer. Co-author DOI 10.1186/s12943-025-02385-9↗
  3. Ubiquitin signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fmolb.2023.1304639↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengnan Lv · 3 shared papers, 2023–2026 · strength 0.73
  2. Feng Wei · 3 shared papers, 2023–2026 · strength 0.73
  3. Yan Liu · 1 shared paper, 2026 · strength 0.29
  4. Bao‐Lian Su · 1 shared paper, 2026 · strength 0.29
  5. Jian Zhang · 1 shared paper, 2023 · strength 0.22
  6. Tongjia Chu · 1 shared paper, 2025 · strength 0.22
  7. Jian Zhang · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.